Dare Bioscience, Inc. Annual Operating Income (Loss) in USD from 2016 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Dare Bioscience, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2024.
  • Dare Bioscience, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$5.39M, a 4.19% decline year-over-year.
  • Dare Bioscience, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$23.5M, a 24.2% increase year-over-year.
  • Dare Bioscience, Inc. annual Operating Income (Loss) for 2024 was -$23.5M, a 24.2% increase from 2023.
  • Dare Bioscience, Inc. annual Operating Income (Loss) for 2023 was -$30.9M, a 1.42% increase from 2022.
  • Dare Bioscience, Inc. annual Operating Income (Loss) for 2022 was -$31.4M, a 19.7% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$23.5M +$7.49M +24.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 -$30.9M +$446K +1.42% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 -$31.4M +$7.68M +19.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$39.1M -$11.7M -42.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$27.4M -$13.1M -91% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$14.3M +$2.54M +15% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 -$16.9M -$5.7M -51% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-27
2017 -$11.2M -$10.5M -1673% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 -$631K Jan 1, 2016 Dec 31, 2016 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.